CHBOF (China Health Technology Group Holding Co) Research & Development: $0.00 Mil (TTM As of Dec. 2025)


CHBOF China Health Technology Group Holding Co Ltd CHBOF
25 GF Score
Price $0.03
GF Value $0.07
! 7 Warning Signs
View Full Analysis

What is China Health Technology Group Holding Co Research & Development?

China Health Technology Group Holding Co CHBOF 25 Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus rates CHBOF with a GF Score™ of 25/100 and a GF Value™ of $0.07. The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. China Health Technology Group Holding Co's Research & Development for the six months ended in Dec. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

China Health Technology Group Holding Co  (OTCPK:CHBOF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

China Health Technology Group Holding Co Research & Development Related Terms

China Health Technology Group Holding Co Research & Development Historical Data

* Premium members only.

The historical data trend for China Health Technology Group Holding Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Health Technology Group Holding Co Research & Development Chart

China Health Technology Group Holding Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

China Health Technology Group Holding Co Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHBOF
25GF Score
China Health Technology Group Holding Co Ltd CHBOF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Health Technology Group Holding Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
China Health Technology Group Holding Co (CHBOF) has a Research & Development of $0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on China Health Technology Group Holding Co and its competitors.
Is China Health Technology Group Holding Co's Research & Development too high?
China Health Technology Group Holding Co's current Research & Development is $0.00 Mil. Overall, China Health Technology Group Holding Co has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does China Health Technology Group Holding Co's Research & Development compare to SSD and UFPI?
China Health Technology Group Holding Co's Research & Development of $0.00 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Forest Products company?
A good Research & Development depends on the Forest Products industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on China Health Technology Group Holding Co and its competitors. China Health Technology Group Holding Co's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Health Technology Group Holding Co stock overvalued right now?
China Health Technology Group Holding Co (CHBOF) has a current Research & Development of $0.00 Mil. The stock's GF Value™ is $0.07, compared to a current price of $0.03 — trading 52.9% below its estimated fair value. The current Research & Development is $0.00 Mil. China Health Technology Group Holding Co's overall GF Score™ is 25/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For China Health Technology Group Holding Co (CHBOF), the current Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Health Technology Group Holding Co (CHBOF) Overvalued in 2026?

Based on GuruFocus' analysis, China Health Technology Group Holding Co stock appears to be undervalued. The current stock price of $0.03 is trading 52.9% below its estimated GF Value™ of $0.07.

Key valuation signals for CHBOF:

  • Research & Development: $0.00 Mil
  • GF Value™: $0.07 vs. price of $0.03 (52.9% below fair value)
  • GF Score™: 25/100 with 7 warning signs

No single metric tells the full story. See the CHBOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Health Technology Group Holding Co Business Description

Other Exchanges 01069:Hong Kong
Address South Binhe Avenue, Room 4903, Building A, West Tower, C Future City, Futian District, Shenzhen, CHN
China Health Technology Group Holding Co Ltd is an investment holding company. It is engaged in the business of management of new agriculture and forestry resources in the People's Republic of China. The company has reportable segments including the Forestry business; Horny Goat Weed Business; Health products business and Ginseng Business. The forestry management business includes plantation, logging, and sale of timber-related products and the Ginseng Business includes ginseng plantation and trading of related products. The company generates a majority of its revenue from the Forestry business segment. Geographically company generates its key revenue from the PRC.
25GF Score

Get the complete analysis for CHBOF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price
$0.07
GF Value